Pfizer Inc. (PFE)
27.80
-0.32
(-1.14%)
USD |
NYSE |
Oct 02, 16:00
27.80
0.00 (0.00%)
After-Hours: 20:00
Pfizer Price : 27.80 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 28.14 | 28.16 | 27.44 | 27.80 | 35.01M |
| Oct 01, 2026 | 28.44 | 28.58 | 28.08 | 28.12 | 30.49M |
| Sep 30, 2026 | 28.79 | 28.94 | 28.52 | 28.52 | 33.64M |
| Sep 29, 2026 | 28.60 | 28.76 | 28.26 | 28.72 | 33.31M |
| Sep 28, 2026 | 28.62 | 28.87 | 28.39 | 28.72 | 24.95M |
| Sep 25, 2026 | 28.45 | 28.69 | 28.17 | 28.67 | 27.76M |
| Sep 24, 2026 | 28.20 | 28.85 | 28.20 | 28.41 | 34.77M |
| Sep 23, 2026 | 27.96 | 28.23 | 27.84 | 28.18 | 33.81M |
| Sep 22, 2026 | 27.74 | 28.00 | 27.49 | 27.93 | 26.67M |
| Sep 21, 2026 | 27.65 | 27.92 | 27.53 | 27.74 | 28.78M |
| Sep 18, 2026 | 27.64 | 27.66 | 27.34 | 27.66 | 75.59M |
| Sep 17, 2026 | 27.62 | 27.81 | 27.55 | 27.64 | 29.01M |
| Sep 16, 2026 | 27.64 | 27.69 | 27.36 | 27.46 | 26.05M |
| Sep 15, 2026 | 27.62 | 27.66 | 27.24 | 27.55 | 40.44M |
| Sep 14, 2026 | 28.08 | 28.19 | 27.68 | 27.72 | 28.57M |
| Sep 11, 2026 | 27.80 | 27.85 | 27.42 | 27.72 | 25.56M |
| Sep 10, 2026 | 27.69 | 27.75 | 27.40 | 27.65 | 28.81M |
| Sep 09, 2026 | 27.76 | 27.98 | 27.57 | 27.78 | 29.14M |
| Sep 08, 2026 | 28.02 | 28.14 | 27.72 | 27.79 | 31.77M |
| Sep 04, 2026 | 28.58 | 28.69 | 28.38 | 28.45 | 23.79M |
| Sep 03, 2026 | 29.09 | 29.21 | 28.44 | 28.81 | 26.72M |
| Sep 02, 2026 | 28.79 | 29.09 | 28.70 | 29.02 | 39.28M |
| Sep 01, 2026 | 28.82 | 29.09 | 28.46 | 28.55 | 42.49M |
| Aug 31, 2026 | 27.85 | 28.70 | 27.64 | 28.46 | 45.93M |
| Aug 28, 2026 | 28.00 | 28.02 | 27.77 | 27.96 | 27.18M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 256.03 |
| Eli Lilly & Co. | 1142.85 |
| Merck & Co., Inc. | 144.30 |
| Bristol Myers Squibb Co. | 61.15 |
| Viatris, Inc. | 17.60 |
Price Related Metrics
| PE Ratio | 36.81 |
| PS Ratio | 2.491 |
| Price to Book Value | 1.860 |
| Price to Free Cash Flow | 14.44 |
| Earnings Yield | 2.72% |
| Market Cap | 158.43B |
| Operating PE Ratio | 9.374 |
| Normalized PE Ratio | 11.47 |